J 2022

Polyphenolic grape stalk and coffee extracts attenuate spinal cord injury‑induced neuropathic pain development in ICR‑CD1 female mice

BAGÓ MAS, Anna, Andrea KORIMOVÁ, Meritxell DEULOFEU FIGUERAS, Enrico VERDÚ, Núria FIOL et. al.

Základní údaje

Originální název

Polyphenolic grape stalk and coffee extracts attenuate spinal cord injury‑induced neuropathic pain development in ICR‑CD1 female mice

Autoři

BAGÓ MAS, Anna (724 Španělsko), Andrea KORIMOVÁ (703 Slovensko, domácí), Meritxell DEULOFEU FIGUERAS (724 Španělsko), Enrico VERDÚ (724 Španělsko), Núria FIOL (203 Česká republika), Viktorie SVOBODOVÁ (203 Česká republika, domácí), Petr DUBOVÝ (203 Česká republika, garant, domácí) a Pere BOADAS-VAELLO (724 Španělsko)

Vydání

Scientific Reports, Berlin, Nature, 2022, 2045-2322

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30103 Neurosciences

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.600

Kód RIV

RIV/00216224:14110/22:00127909

Organizační jednotka

Lékařská fakulta

UT WoS

000849436000038

Klíčová slova anglicky

GALLIC ACID; CHLOROGENIC ACID; INFLAMMATORY RESPONSES; CENTRAL SENSITIZATION; DORSAL-HORN; CATHEPSIN-S; EXPRESSION; MICROGLIA; FRACTALKINE; PREVALENCE

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 25. 1. 2023 10:59, Mgr. Tereza Miškechová

Anotace

V originále

More than half of spinal cord injury (SCI) patients develop central neuropathic pain (CNP), which is largely refractory to current treatments. Considering the preclinical evidence showing that polyphenolic compounds may exert antinociceptive effects, the present work aimed to study preventive effects on SCI-induced CNP development by repeated administration of two vegetal polyphenolic extracts: grape stalk extract (GSE) and coffee extract (CE). Thermal hyperalgesia and mechanical allodynia were evaluated at 7, 14 and 21 days postinjury. Then, gliosis, ERK phosphorylation and the expression of CCL2 and CX3CL1 chemokines and their receptors, CCR2 and CX3CR1, were analyzed in the spinal cord. Gliosis and CX3CL1/CX3CR1 expression were also analyzed in the anterior cingulate cortex (ACC) and periaqueductal gray matter (PAG) since they are supraspinal structures involved in pain perception and modulation. GSE and CE treatments modulated pain behaviors accompanied by reduced gliosis in the spinal cord and both treatments modulated neuronglia crosstalk-related biomolecules expression. Moreover, both extracts attenuated astrogliosis in the ACC and PAG as well as microgliosis in the ACC with an increased M2 subpopulation of microglial cells in the PAG. Finally, GSE and CE prevented CX3CL1/CX3CR1 upregulation in the PAG, and modulated their expression in ACC. These findings suggest that repeated administrations of either GSE or CE after SCI may be suitable pharmacologic strategies to attenuate SCI-induced CNP development by means of spinal and supraspinal neuroinflammation modulation.